Annual Update in Pulmonary Hypertension

The Annual Update in Pulmonary Hypertension is a distinguished educational event hosted at The Westin Copley Place in Boston, United States. This symposium is recognized as the only one in New England focused on the latest advancements in understanding and managing pulmonary vascular disorders, particularly pulmonary hypertension (PH). It is specifically designed to cater to healthcare professionals including pulmonologists, cardiologists, rheumatologists, general practitioners, fellows, residents, nurse practitioners, and registered nurses who are engaged in caring for patients with pulmonary arterial hypertension.The event will feature a series of comprehensive educational formats including didactic lectures, case-based plenary sessions, and breakout discussions led by leading experts in the field. Participants will benefit from a curriculum that is grounded in current evidence-based guidelines and research, emphasizing patient-centered outcomes. Attendees are expected to gain insights that will aid in making informed treatment decisions, which in turn will aim to improve patient outcomes significantly.Key learning objectives of the symposium include reviewing clinical trial evidence on the safety and efficacy of emerging drug treatments for PH, evaluating new and existing therapeutic options for interstitial lung disease-related pulmonary hypertension (ILD-PH), and utilizing an interactive case-based approach for managing PH patients with challenging comorbid conditions. Attendees will also develop evidence-based management plans that integrate imaging modalities and pharmacologic strategies, discuss combination therapies, and assess guideline-directed medical therapy for heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF).The symposium aims to foster a collaborative model of care between patients, families, and healthcare providers to enhance shared decision-making. Notable speakers for this year's event include Colin Church, MB ChB, PhD, and John Ryan, MD, MB BCh, BAO, who will contribute their expertise in advancing the discussion on the complexities of treatment decisions for patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) and differences from CTD-associated ILD-PH. Overall, the Annual Update in Pulmonary Hypertension promises to be a vital opportunity for healthcare practitioners in various countries, including the UAE, Mexico, Saudi Arabia, and the USA, to stay updated on the latest developments in the field.